diphenyl has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, MH; Wang, JX; Wang, XD; Yu, BY; Zhang, SQ | 1 |
| Arojojoye, AS; Awuah, SG; Gukathasan, S; Kim, JH; Olelewe, C; Parkin, S; Sullivan, PG; Vekaria, H | 1 |
2 other study(ies) available for diphenyl and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Non-fused imidazole-biphenyl analogs repress triple-negative breast cancer growth by mainly stabilizing the c-MYC G-quadruplex via a multi-site binding mode.
Topics: Antineoplastic Agents; G-Quadruplexes; Humans; Imidazoles; Ligands; Proto-Oncogene Proteins c-myc; Triple Negative Breast Neoplasms | 2023 |
Serum-Stable Gold(III) Bisphosphine Complex Induces Mild Mitochondrial Uncoupling and In Vivo Antitumor Potency in Triple Negative Breast Cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Gold; Humans; Mice; Mitochondria; Organogold Compounds; Serum; Triple Negative Breast Neoplasms | 2023 |